中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Advances in studies on novel agents against Helicobacter pylori

文献类型:期刊论文

作者Liu Qing; Wang Mingwei
刊名Chinese Bulletin of Life Sciences
出版日期2005
卷号17期号:3页码:211-217
关键词research progress anti-Helicobacter pylori drugs
ISSN号1004-0374
其他题名抗幽门螺杆菌药物的研究进展
文献子类Article
英文摘要Helicobacter pylori is a well-recognized cause for gastritis, peptic ulcer and carcinoma of the stomach. With wide use of broad-spectrum antibiotics, drug-resistant strains of Helicobacter pylori have been emerged in a rapid pace. Development of highly efficacious and selective agents against Helicobacter pylori is thus becoming a focal point that attracts global attention. This article reviews a series of new drugs or lead candi-dates with inhibitory effects on Helicobacter pylori reported in the literature during recent five years, with an aim of providing some useful insights to research and development of novel drugs to treat Helicobacter pylori infection.
资助项目国家重大科技专项基金[00000000] ; 中国科学院知识创新工程重大项目基金[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:1966077
源URL[http://119.78.100.183/handle/2S10ELR8/268342]  
专题国家新药筛选中心
作者单位National Center for Drug Screening, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Liu Qing,Wang Mingwei. Advances in studies on novel agents against Helicobacter pylori[J]. Chinese Bulletin of Life Sciences,2005,17(3):211-217.
APA Liu Qing,&Wang Mingwei.(2005).Advances in studies on novel agents against Helicobacter pylori.Chinese Bulletin of Life Sciences,17(3),211-217.
MLA Liu Qing,et al."Advances in studies on novel agents against Helicobacter pylori".Chinese Bulletin of Life Sciences 17.3(2005):211-217.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。